Heineken has announced it plans to sell its production site in Kaliningrad, Russia, as it aims to raise RUB 250 million ($4.3 million).
Production at the site in the Russian enclave were reportedly stopped in January as a result of sustained inflation, unfavourable exchange rates, low consumer confidence and high price competition.
Heineken said in a statement: “We have a sober estimate of the economic situation in the country as a whole and in the region in particular.”
The site consists of warehouses and five plots of land with a total area of 7.2 hectares. Heineken said its aims to use the money from the sale to invest in other projects.
Cécile Béliot has assumed the role of Bel Group chief executive officer, following the decision to separate the roles of chairman and CEO. The separation of the functions will enable Bel Group to develop in three areas of healthy snacking. Meanwhile, the company’s former CEO, Antoine Fiévet, has had his mandate renewed as chairman of the board.
US Food and Drug Administration (FDA) Commissioner Dr. Robert Califf was grilled by lawmakers during a House Appropriations subcommittee hearing, where he was slammed over the agency’s handling of the escalating infant formula shortage.
Sweegen is ramping up its efforts to reduce sugar across F&B applications while simultaneously tapping into the benefits of using antioxidants and bitter blocking technology. Speaking to FoodIngredientsFirst, Casey McCormick, vice president of global innovation at Sweegen, says product developers can find a broad range of solutions in Sweegen’s nature-based sweetener systems as brands elevate better-for-you foods.